Martine A Rothblatt sold $5.1M of UTHR
Chairperson & CEO at UNITED THERAPEUTICS Corp. 9,500 shares at an average of $538.67, traded Oct 6, 2026, filed Oct 7, 2026.
Score components
- +25RoleCEO
- +25Trade size$5.1M at market
- 0Share of holdings soldSold 2.8% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001106578-26-000158, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 6, 2026 | MOption exercise Common Stockindirect: by Trust10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 | 4 d ago |
| Oct 6, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -280 | $527.90 | $148k | 333,663 | 4 d ago |
| Oct 6, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -360 | $528.72 | $190k | 333,303 | 4 d ago |
| Oct 6, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -240 | $530.13 | $127k | 333,063 | 4 d ago |
| Oct 6, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -320 | $531.94 | $170k | 332,743 | 4 d ago |
| Oct 6, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -215 | $533.14 | $115k | 332,528 | 4 d ago |
| Oct 6, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -167 | $534.30 | $89k | 332,361 | 4 d ago |
| Oct 6, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -734 | $535.71 | $393k | 331,627 | 4 d ago |
| Oct 6, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -323 | $536.25 | $173k | 331,304 | 4 d ago |
| Oct 6, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -133 | $537.58 | $71k | 331,171 | 4 d ago |
| Oct 6, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -1,088 | $538.61 | $586k | 330,083 | 4 d ago |
| Oct 6, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -1,606 | $539.68 | $867k | 328,477 | 4 d ago |
| Oct 6, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -2,054 | $540.68 | $1.1M | 326,423 | 4 d ago |
| Oct 6, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -380 | $541.55 | $206k | 326,043 | 4 d ago |
| Oct 6, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -120 | $542.49 | $65k | 325,923 | 4 d ago |
| Oct 6, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -558 | $543.99 | $304k | 325,365 | 4 d ago |
| Oct 6, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -842 | $544.75 | $459k | 324,523 | 4 d ago |
| Oct 6, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -80 | $545.50 | $44k | 324,443 | 4 d ago |
| Oct 6, 2026 | MOption exercise Stock Optionderivativeindirect: by Trust10b5-1 | -9,500 | $0.00 | $0 | 290,410 | 4 d ago |
Related signals
Other insiders at UNITED THERAPEUTICS Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.2M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.2M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.5M 9,500 shares | -3% | |
| 18Weak | UNITED THERAPEUTICS Corp | Paul A Mahon EVP & GENERAL COUNSEL | $4.7M 8,300 shares | -16% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $3.9M 7,580 shares | -2% | |
| 38Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $1.1M 1,920 shares | -1% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $4.5M 9,500 shares | -3% | |
| 30Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $4.6M 9,500 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.